We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Theracryf Plc | TCF | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.5375 | 0.5375 | 0.5375 | 0.5375 | 0.5375 |
Industry Sector |
---|
EQUITY INVESTMENT INSTRUMENTS |
Top Posts |
---|
Posted at 06/11/2024 14:30 by clocktower One wonders what story Huw spun when he got the new investors aboard at 1p, as all they have seen is the same decline as we saw from October 2022. |
Posted at 05/11/2024 18:18 by lovewinshatelosses Yep. Final tranche today. It was an aggregate meaty loss, but AIM education costs money, so cheap in that sense :)Did not try to dump the lot in one go, because I probably would not have even got the lowest price, which was the print today. Touch wood, I have done fairly well in the past few years, so the dent in the p/f has long since been smoothed over. Luckily I did not keep pouring more good money after bad in this one, since my last purchase here (cannot remember exactly when it was). Bitterness will not get your money back, so always best to try and take it on the chin and learn from it, IMO. Even with the dodgy names, which the authorities seem reluctant to deal with (again IMO). Not saying this is one of those, but I think you could make a compelling case for investors having, at the very least, being badly misled here over a few years now. Ground which has already been covered extensively over quite some time, so no need for me to repeat it. Good luck to you too and I hope your investments and trades elsewhere prosper. |
Posted at 05/11/2024 13:08 by clocktower Will Stalicla be able to raise a larger Series C round, and can it find new larger investment funds to support them? |
Posted at 01/11/2024 11:58 by clocktower I am not familiar with the UK tax regime but reading about the capital gains tax changes, would I be correct that some ISA investors might have been selling up across the board to ensure they were not going to be hit by the recent budget?Selling their whole portfolio even if it included duffers like this, which would be responsible in part for the very low share price. I would appreciate it is someone could enlighten me on the subject. |
Posted at 18/7/2024 20:57 by clocktower I was just taking a look at the vote breakdown, and surprisingly Dr Huw Jones received more votes than Dr Alan Barge and Toni Heanninen. |
Posted at 11/7/2024 12:35 by clocktower Almost back at square one today, which in light of yesterdays news is surprising.It seems to show the market is mainly traders rather than investors now. |
Posted at 28/5/2024 07:22 by clocktower TD - What you have top ask yourself, is why were certain investors happy to put up money at 1p a short time ago, as they would have had the full knowledge of what was expected.I am waiting to see the buying kick in later. |
Posted at 22/5/2024 11:03 by clocktower Well peterm10, it has kick started a bit of buying, and does seem like a positive start to more company activity and possibly investor news on a more regular basis.I also note they do still mention Stalicla in the RNS, although a small note,it remains. I guess it might take a few more buys for it to tick up though but a little surprised, that after the more positive research note, and this RNS that the buying has not continued. |
Posted at 10/5/2024 06:12 by terrydevlin1 I agree with your comment Clock Tower. It is incredibly disappointing to have no new deals signed up for SFX-01 since the Stalicla deal. There seems so little news now about SFX-01 in the past 10 months.The sad reality is that TCF cannot afford to do their own trials so they cannot do much to prove the drug is effective and it seems like they cannot get anyone to trial it for them. The Stalicla deal is so huge to TCF that they have no option but to wait for Stalicla to decide what they will do and when they will do it. It is TCF’s only potential income stream and money is running out. It is over a quarter of a year since the dispute was issued and no news at all. It doesn’t feel like there will be any news any time soon either. I feel for all investors who invested as a result of the Stalicla deal announcement in 2022. At that time with £10m in the bank, Juvenesense having a deal with SFX-01 and milestone payments of up to $160m with Stalicla it seemed like this share had great potential. I wish I never had stumbled on that RNS. |
Posted at 10/9/2012 11:38 by praipus As you may know I track Laxeys holdings on the WAM thread and their number of BUY trades has definitiely reduced compared to the other active investors. And their number of SELL trades has increased!If with all their resources researchers and analysts they can't make money what chance have us PI's got? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions